EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ:SVNT), a biopharmaceutical company focused on developing, manufacturing and marketing novel therapeutic products for unmet medical needs, today announced that Christopher Clement, President and Chief Executive Officer of Savient Pharmaceuticals, will present a corporate update at the upcoming Lazard Capital Markets Third Annual Life Sciences Conference. The presentation is scheduled for 8:30 AM (Eastern Time) on Wednesday, November 29, 2006. The event will be held from November 28 - 29, 2006 at the New York Palace Hotel in New York City.
